March 20, 2026 · Form 4 insider transaction
HEGGIE THERESA sold 49,933 shares of BioCryst Pharmaceuticals, Inc. at $10.11 per share, a transaction worth $504.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.09 to $10.14. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.